secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001140361-23-015159
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STRATA Skin Sciences reports record Q4 revenue of $10.6M; FY 2023 guidance $38M-$40M
--------------------------------------------------------------------------------

- Q4 2022 revenue $10.6M (+17% YoY); full-year revenue $36.2M (+21% YoY).
- Net loss narrowed to $0.2M in Q4 ($0.005/share) vs $0.8M loss in Q4 2021; full-year net loss $5.5M vs $2.7M.
- Domestic installed base of 909 XTRAC devices; acquired TheraClearX acne device in Jan 2022.
- FY 2023 revenue guidance of $38M-$40M; entered Mexican market with distribution agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123015159/0001140361-23-015159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123015159/brhc10050694_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-015159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer